Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-07-20Clinical Trial Update: Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer
This completed clinical study evaluates comprehensive screening for women at high genetic risk of developing breast cancer.
-
CLINICAL_TRIALS trial_result · 2010-07-19Clinical Trial Update: Pilot Study: Age Extension of NHS Breast Screening Programme [NA]
This is a completed pilot study evaluating extending the NHS Breast Screening Programme to older ages. It uses routine mammography to screen…
-
CLINICAL_TRIALS trial_result · 2010-07-19Clinical Trial Update: Lymphatic Mapping After Previous Breast Surgery
This completed clinical trial reports on lymphatic mapping after prior breast surgery, in the setting of breast cancer and sentinel node ass…
-
CLINICAL_TRIALS trial_result · 2010-07-15Clinical Trial Update: Multihance Versus Magnevist in Breast MRI [Phase 3]
Phase 3 trial comparing MRI contrast agents Multihance and Magnevist in breast imaging has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: A Pilot Clinical Trial With Tocotrienol on Breast Cancer [NA]
A pilot clinical trial evaluating tocotrienol for breast cancer has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2010-06-29Clinical Trial Update: 10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)
This completed clinical trial evaluates 10-year coronary heart disease risk and treatment patterns in postmenopausal women with early breast…
-
FDA approval · 2010-06-28FDA Approved: ANASTROZOLE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's original application for generic anastrozole.
-
FDA approval · 2010-06-28FDA Approved: ANASTROZOLE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's original application for a generic anastrozole product, expanding access to this aromatase inhibitor for breast cancer t…
-
FDA approval · 2010-06-28FDA Approved: ANASTROZOLE — Original Application (Natco Pharma Limited)
This FDA page confirms Natco Pharma Limited's original approval of a generic anastrozole product for the treatment of hormone receptor-posit…
-
FDA approval · 2010-06-28FDA Approved: ANASTROZOLE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for generic anastrozole from Zydus Lifesciences Limited, used to treat hormone receptor-positive breas…
-
FDA approval · 2010-06-25FDA Approved: FEMARA — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for FEMARA (letrozole) from Novartis Pharmaceuticals Corporation, updating the labeling for breast c…
-
CLINICAL_TRIALS trial_result · 2010-06-15Clinical Trial Update: Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy. [Phase 3]
A Phase 3 trial comparing two doses of fulvestrant (250 mg vs 500 mg) in postmenopausal women with estrogen receptor–positive advanced breas…
-
CLINICAL_TRIALS trial_result · 2010-06-14Clinical Trial Update: Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO) [Phase 2]
This clinical trial update reports on a Phase 2 study (ZORO) evaluating whether goserelin can prevent chemotherapy-induced ovarian failure i…
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer [Phase 2]
This update documents a completed Phase 2 trial evaluating a combination chemotherapy regimen for metastatic breast cancer.
-
CLINICAL_TRIALS research · 2010-06-11Clinical Trial Update: Chronic Post Breast Surgery Pain [NA]
A Mayo Clinic–sponsored clinical trial investigating chronic pain after breast surgery in breast cancer patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Manual Therapy in Postoperative Breast Cancer [NA]
A completed clinical trial from the University of Campinas evaluated manual therapy to address postoperative shoulder joint limitation in br…
-
CLINICAL_TRIALS withdrawal · 2010-06-10Clinical Trial Update: Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer [Phase 2]
A Phase 2 trial of allogeneic transplantation with mini-conditioning for stage IV breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2010-06-03Clinical Trial Update: Clinical Evaluation of OSNA Breast Cancer System to Test Sentinel Lymph Nodes From Patients With Breast Cancer
This clinical trial update reports the completion of evaluating the OSNA Breast Cancer System for testing sentinel lymph nodes in patients w…
-
CLINICAL_TRIALS research · 2010-06-03Clinical Trial Update: Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian Cancer
This clinical trial update discusses using thymidine kinase 1 as a biomarker for risk assessment in hereditary breast and ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2010-06-02Clinical Trial Update: Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer [Phase 2]
Phase 2 trial evaluating lapatinib in combination with chemotherapy for relapsed breast cancer; the study was terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2010-06-02Clinical Trial Update: Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer [Phase 3]
Phase 3 trial evaluating arzoxifene for fracture reduction and incidence of breast cancer in postmenopausal osteoporosis; the study has comp…
-
FDA approval · 2010-05-26FDA Approved: VINORELBINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Vinorelbine from Actavis Pharma, Inc., indicating an update to its labeling/indications.
-
CLINICAL_TRIALS trial_result · 2010-05-25Clinical Trial Update: Effects of Hands-on-Healing vs. Touch for Fatigued Breast Cancer Survivors [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating Hands-on-Healing versus standard touch for fatigue in breast cancer survivors.
-
CLINICAL_TRIALS trial_result · 2010-05-20Clinical Trial Update: Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422) [Phase 1]
Phase 1 study evaluating KS2422, a CD80-modified allogeneic cancer cell line, as a vaccine for metastatic breast cancer. The trial status is…
-
CLINICAL_TRIALS trial_result · 2010-05-19Clinical Trial Update: Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer [Phase 2]
An open-label Phase 2 trial evaluated SU011248 in combination with trastuzumab for metastatic breast cancer; results were posted in May 2010…